Two REMS, Two Names, One Drug: Is It Safe? FDA Questions Jazz's Proposal For Fibromyalgia Indication
This article was originally published in The Pink Sheet Daily
Executive Summary
Advisory panel on sodium oxybate will weigh whether separate REMS for Xyrem and proposed Rekinla can prevent medication errors and abuse.